ST-segment elevation myocardial infarction (STEMI)

Latest STEMI content in interventional cardiology - research, practice, and education

Treating STEMI brings into play a series of clinical and organisational protocols in constant evolution. Today, patients presenting with STEMI are best treated by early reperfusion strategies of which primary PCI is the preferred method. Keep up-to-date on the role of adjunctive pharmacotherapy, advances in imaging techniques and the use of invasive imaging and functional assessment. Tools, devices and techniques as well as complications, such as the different types of vascular access or bleeding risk can be found here as well…

Filtered By
STEMI

412 results

Optimal SCAD treatment

22 May 2025 – From EuroPCR 2025

Navigate the complexities of spontaneous coronary artery dissection (SCAD) treatment through clinical case discussions. This session explores identifying the culprit lesion, recurrent ACS challenges, the conservative versus PCI treatment dilemma, and real-world presentation scenarios emphasizing decision-making in SCAD management.

Optimal SCAD treatment

High thrombus burden in STEMI

22 May 2025 – From EuroPCR 2025

This session addresses the management of high thrombus burden in STEMI patients. It reviews available tools and strategies for thrombus management, presents multiple case-based discussions illustrating treatment decisions, and explores the evolving role of thrombus aspiration in contemporary practice.

High thrombus burden in STEMI

Calcified un-dilatable lesions in ACS: what should I do?

22 May 2025 – From EuroPCR 2025

Address the challenges of severely calcified undilatable lesions during acute coronary syndrome PCI. This session reviews the impact of coronary calcification on PCI strategy, highlights pitfalls in lesion preparation, and presents detailed case studies demonstrating effective treatment approaches.

Calcified un-dilatable lesions in ACS: what should I do?

Should STEMI treatment be related to specific clinical patient characteristics

22 May 2025 – From EuroPCR 2025

This session evaluates whether STEMI treatment should be tailored to specific clinical patient characteristics. It includes insights into STEMI management in very young patients, benefits of revascularisation of LAD non-culprit lesions in older AMI patients, clinical outcomes from the NAMI registry for young STEMI patients, and...

Should STEMI treatment be related to specific clinical patient characteristics

High-risk PCI in acute coronary syndrome

22 May 2025 – From EuroPCR 2025

Explore high-risk PCI strategies in acute coronary syndrome patients who are unsuitable for surgery. This session presents insights on Killip class influence, haemodynamic support with micro-axial flow pumps, disease progression patterns in complicated STEMI, and the prognostic value of QFR-guided functional SYNTAX scores in ACS management.

High-risk PCI in acute coronary syndrome

Bifurcation CAD: presentation and PCI strategies

22 May 2025 – From EuroPCR 2025

Navigate the complexities of coronary bifurcation disease with a comprehensive session covering decision-making, imaging applications, and PCI strategies. Review clinical scenarios involving left main disease, calcifications, and acute presentations. Understand the pivotal role of intracoronary imaging and explore provisional and two-stent techniques through detailed case discussions...

Bifurcation CAD: presentation and PCI strategies

STEMI in special circumstances

22 May 2025 – From EuroPCR 2025

Address STEMI management in special circumstances such as spontaneous coronary artery dissection, ectatic vessels, and high thrombotic burden. Learn when surgical referral is appropriate and explore interventional strategies tailored to complex STEMI presentations.

STEMI in special circumstances

Spotlight on major Late-Breaking Trials presented at EuroPCR 2025

21 May 2025

These trials were selected because of their design, results, and potential to impact practice: Discover the key findings of the 4D-ACS and FAITAVI randomised clinical trials and a meta-analysis of PROTECTED TAVR and BHF PROTECT TAVI.

Selection of top Late-breaking Trials presented at #EuroPCR

Redefining complex PCI: impact of real-world data and novel evidence on IV antithrombotic strategies

21 May 2025 – From EuroPCR 2025

Explore how real-world data and evolving evidence are reshaping IV antithrombotic strategies in complex PCI. This EuroPCR 2025 session brings together urgent clinical cases—including STEMI patients in shock—and highlights key insights from the SMILE registry. Learn how transition protocols from cangrelor to oral P2Y12 inhibitors are...

Redefining complex PCI: impact of real-world data and novel evidence on IV antithrombotic strategies

Unconventional situations and complications during cardiovascular interventions

21 May 2025 – From EuroPCR 2025

Explore this session to gain expert tips and practical strategies for managing unexpected complications during cardiovascular interventions. Learn how to anticipate and avoid complications in conventional procedures and discover different approaches to tackle challenging situations in the cathlab through detailed case discussions involving PCI, TAVI, and...

Unconventional situations and complications during cardiovascular interventions